Posts Tagged ‘ribavirin’

MAY 15: SCIENCE DAILY: A ground-breaking Canada-wide clinical trial has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients, including prostate. The study demonstrates that ribavirin suppresses the activities of the eIF4E gene in patients. This gene is dysregulated in 30 percent of cancers including breast, prostate, head and neck, colon and stomach cancer. READ MORE>

Read Full Post »